{"result": {"id": "chatcmpl-810", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **FUTURE-C-PLUS** phase 2 clinical trial is an investigation into the use of immunotherapy for treating triple-negative breast cancer (TNBC). This trial focuses on advanced immunomodulatory TNBC patients.  It's a Phase II study, meaning it aims to evaluate the effectiveness and safety of the treatment in a smaller group of patients. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743141891, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 75, "prompt_tokens": 167, "total_tokens": 242, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"FUTURE-C-PLUS\"\nDescription List: [\"Phase 2 clinical trial investigating TNBC immunotherapy\", \"Phase II clinical trial for advanced immunomodulatory TNBC patients\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_a5ab258c26b35a26a68f64973fa390da58740ea85a47f8df179e7bf3c77f21c2_v2"}